Publications by authors named "Giulia Manfredi"

Claim this Profile
L
Lenvatinib sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study.
Pasquale Lombardi, Jung Sun Kim, Giulia F Manfredi, Ciro Celsa, Claudia A M Fulgenzi

JHEP Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis.
Ciro Celsa, Gabriele Di Maria, Pasquale Lombardi, Antonio D'Alessio, Claudia A M Fulgenzi, Giulia F Manfredi

JAMA Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence.
Giulia Francesca Manfredi, Claudia Angela Maria Fulgenzi, Ciro Celsa, Bernardo Stefanini, Antonio D'Alessio

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effectiveness, safety, and liver stiffness dynamics of PBC treatment with obeticholic acid in real-world.
Francesca Terracciani, Antonio De Vincentis, Daphne D'Amato, Laura Cristoferi, Alessio Gerussi, Giulia Francesca Manfredi

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective cohort study on treatment outcomes of early vs late onset gestational diabetes mellitus.
Riccardo Candido, Barbara Toffoli, Giulia Manfredi, Anna Turisani, Veronica Delfauro

Acta Diabetol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving landscape of autoimmune hepatitis: an ambispective cohort study.
Cristina Rigamonti, Irene Giacone, Giulia Francesca Manfredi, Micol Giulia Cittone, Mario Pirisi

Intern Emerg Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab.
Bernardo Stefanini, Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz, Jaekyung Cheon, Giulia Francesca Manfredi

J Hepatocell Carcinoma· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid Metastases From Renal Cell Carcinoma Presenting as Thyroid Nodules With Involvement of an Adjacent Vein.
Veronica Calabrò, Chiara Dobrinja, Marco Francesco Maria Cavallaro, Giulia Manfredi, Claudia Di Lecce

AACE Endocrinol Diabetes· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Salvatore Battaglia, Marco Enea, Giulia F Manfredi

Hepatology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death.
Giuseppe Cabibbo, Ciro Celsa, Salvatore Battaglia, Marco Enea, Gabriele Di Maria, Giulia F Manfredi

Clin Cancer Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab.
Meng Wu, Claudia A M Fulgenzi, Antonio D'Alessio, Alessio Cortellini, Ciro Celsa, Giulia F Manfredi

JHEP Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of systematic compression ultrasonography for the detection of unrecognized venous thromboembolism in patients admitted to an internal medicine ward for dyspnea.
Daniele Sola, Ramona Bonometti, Giulia Comola, Giulia Francesca Manfredi, Mattia Perazzi

Intern Emerg Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Age and Sex on Viral Load in Hepatitis C Virus Infection.
Andrea Magri, Giulia Francesca Manfredi, Carlo Smirne, Silvia Pigni, Michela Emma Burlone

Viruses· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis.
Antonio D'Alessio, Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Giulia Francesca Manfredi

Lancet Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma.
Bernardo Stefanini, Giulia F Manfredi, Antonio D'Alessio, Claudia A M Fulgenzi, Nichola Awosika

Expert Rev Gastroenterol Hepatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction.
Claudia Angela Maria Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, Aman Mehan, Giulia F Manfredi

JAMA Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
Ciro Celsa, Giuseppe Cabibbo, Claudia A M Fulgenzi, Bernhard Scheiner, Antonio D'Alessio, Giulia F Manfredi

J Hepatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammation as a Pathogenic Mechanism of Colonic Neoplasia in Primary Sclerosing Cholangitis.
Giulia F Manfredi, David J Pinato

Gastroenterology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spleen stiffness measurement predicts decompensation and rules out high-risk oesophageal varices in primary biliary cholangitis.
Cristina Rigamonti, Micol Giulia Cittone, Giulia Francesca Manfredi, Carla De Benedittis, Noemi Paggi

JHEP Rep· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma.
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti

J Hepatocell Carcinoma· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The price and value of therapeutic synergy in liver cancer.
David J Pinato, Antonio D'Alessio, Ciro Celsa, Giulia F Manfredi, Claudia A M Fulgenzi

Lancet· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years.
Cristina Rigamonti, Carla De Benedittis, Sara Labanca, Ester Vanni, Anna Morgando, Giulia Francesca Manfredi

Eur J Gastroenterol Hepatol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing?
Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David James Pinato

Ther Adv Med Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High reproducibility of spleen stiffness measurement by vibration-controlled transient elastography with a spleen-dedicated module.
Cristina Rigamonti, Micol Giulia Cittone, Giulia Francesca Manfredi, Andrea Sorge, Riccardo Moia

Hepatol Commun· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D in Systemic Sclerosis: A Review.
Mattia Perazzi, Enrico Gallina, Giulia Francesca Manfredi, Filippo Patrucco, Antonio Acquaviva

Nutrients· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis